Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-871-7 | CAS number: 111-45-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2020-07-20 to 2020-09-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: EU method B.59: In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA)
- Version / remarks:
- 2017-02-14
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2020-06-26
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
- Justification for non-LLNA method:
- The direct peptide reactivity assay can be used as part of a testing battery (including e.g. h-CLAT (human Cell Line Activation Test), ARE-Nrf2 luciferase test method) based on the OECD adverse outcome pathway for the assessment of the skin sensitisation potential of chemicals.
Test material
- Reference substance name:
- 2-(allyloxy)ethanol
- EC Number:
- 203-871-7
- EC Name:
- 2-(allyloxy)ethanol
- Cas Number:
- 111-45-5
- Molecular formula:
- C5H10O2
- IUPAC Name:
- 2-(prop-2-en-1-yloxy)ethan-1-ol
- Test material form:
- liquid
Constituent 1
In chemico test system
- Details on the study design:
- TEST CHEMICALS
Synthetic peptides:
- Peptides with 95.8 % (cysteine) and 93.84 % (lysine) purity
- Sequence cysteine peptides: Ac-RFAACAA-OH (MW = 750.9 g/mol)
- Sequence lysine-Peptide: Ac-RFAAKAA-OH (MW = 775.9 g/mol)
Buffers:
- Phosphate buffer pH 7.5 ± 0.05
- Ammonium acetate buffer pH 10.2 ± 0.05
Peptide Stock Solutions:
- Cysteine peptide stock solution: 0.667 mM, 0.501 mg/mL
- Lysine peptide stock solution: 0.667 mM, 0.518 mg/mL
Control samples:
- Reference control A (system suitability): Peptide stock solutions combined with acetonitrile, 3 replicates
- Reference control B (stability of the peptides): Peptide stock solutions combined with acetonitrile and measured before and after the reaction, 3 replicates
- Reference control C (solvent control): Peptide stock solutions combined with the respective solvent of the test item (and acetonitrile in case of cysteine peptide), 3 replicates
- Positive control (cinnamaldehyde): Peptide stock solutions combined with positive control stock solution (100 mM) (and acetonitrile in case of cysteine peptide), 3 replicates
- Co-elution controls (test item and peptide coelution): Test item stock solution (and acetonitrile in case of cysteine peptide) combined with the respective buffer solutions in each run
Calibration solutions:
Six calibration standard points were prepared by serial dilution of the peptide stock solutions with the following nominal molarities: STD 1 = 0.534 mM, STD 2 = 0.267 mM, STD 3 = 0.1335 mM, STD 4 = 0.0667 mM, STD 5 = 0.0334 mM and STD 6 = 0.0167 mM. As dilution buffer a 20% acetonitrile buffer solution (phosphate or ammonium acetate) was used. For the zero standard point (STD 7 = 0 mM) dilution buffer was used.
TREATMENT
Peptide stock solutions (750 µL) were combined with test item/positive control/solvent stock solutions (50 µL for cysteine peptides or 250 µL for lysine peptides) were combined and placed to the HPLC autosampler for 24 ± 2 h incubation at 22.5 - 30 °C in the dark. HPLC analysis of the batch of reaction samples started 24 ± 2 h hours after the test chemical was added to the peptide solution. The batches consisted of 2 parts: one part with the A reference controls, the calibration standards and the co-elution controls. These samples could be run before the 24 ± 2 h incubation time ends and right before the other part started or right after the other part. The other part contained the B and C reference controls, the positive controls and the reaction samples and these samples were run right after the 24 ± 2 h incubation time ended. The total HPLC analysis time was less than 21 hours. 3 replicates of reaction samples were measured.
TECHNICAL EQUIPMENT
- HPLC: Shimadzu LC-2030i Prominence (serial number L21445402951AE)
- Detector: D2 lamp (220 nm)
- Column: Zorbax SB-C18 (2.1 x 100 mm, 3.5 μm)
- Column temperature: 30°C
- Sample temperature: 25°C
- Injection volume: 7 µL
- System equilibration: running mobile phase A and mobile phase B in a ratio of 1:1 for 2 hours at 30°C column temperature and running the gradient twice before injecting the first sample
- Run time: 20 min
- Mobile Phase A: 0.100 % (v/v) trifluoroacetic acid in ultrapure water
- Mobile Phase B: 0.085 % (v/v) trifluoroacetic acid in acetonitrile
Results and discussion
- Positive control results:
- The acceptance criteria were met for the positive control with a cysteine peptide depletion value of 65.49 % ± 0.31 % and a mean lysine peptide depletion value of 52.71 % ± 0.87 %.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: mean peptide depletion (%) for cysteine
- Value:
- 9.4
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: mean peptide depletion (%) for lysine
- Value:
- 1.27
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: mean peptide depletion of both peptides (%)
- Value:
- 5.34
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
Any other information on results incl. tables
Co-elution: The test chemical did not absorb at 220 nm significantly (since the peak of co-elution control did not reach 10 % compared to the respective reference control) when tested with the cysteine and lysine peptides. Therefore, no co-elution was observed with either of the peptides. The range of retention time for cysteine peptide was between 8.229 and 8.458 and the range of retention time for lysine peptide was between 6.126 and 6.283.
System suitability: Reference control A replicates were included in the HPLC run sequence to verify the HPLC system suitability prior to analysis. The mean peptide concentration of reference control A sample replicates was 0.50 mM for the cysteine and 0.49 mM for the lysine peptide.
Table 2: Cysteine peptide depletion values for the positive control and the test item
Sample | Peptide conc. Calculated (mM) | Mean peptide conc. (mM) | Peptide depletion (%) | Standard deviation (SD) for peptide depletion (%) |
CINNAMALDEHYDE, rep I | 0.16 |
0.16 | 65.72 % |
0.31 % |
CINNAMALDEHYDE, rep II | 0.16 | 65.14 % | ||
CINNAMALDEHYDE, rep III | 0.16 | 65.62 % | ||
Test item, rep I | 0.46 |
0.44 | 4.82 % |
7.27 % |
Test item, rep II | 0.40 | 17.78 % | ||
Test item, rep III | 0.46 | 5.59 % |
Table 3: Lysine peptide depletion values for the positive control and the test item
Sample | Peptide conc. Calculated (mM) | Mean peptide conc. (mM) | Peptide depletion (%) | Standard deviation (SD) for peptide depletion (%) |
CINNAMALDEHYDE, rep I | 0.23 |
0.23 | 53.68 % |
0.87 % |
CINNAMALDEHYDE, rep II | 0.24 | 51.99 % | ||
CINNAMALDEHYDE, rep III | 0.23 | 52.46 % | ||
Test item, rep I | 0.48 |
0.49 | 2.09 % |
0.71 % |
Test item, rep II | 0.49 | 0.82 % | ||
Test item, rep III | 0.49 | 0.91 % |
Applicant's summary and conclusion
- Interpretation of results:
- other: No peptide reactivity
- Conclusions:
- Based on these results and the cysteine 1:10 / lysine 1:50 prediction model, the test item showed no or minimal reactivity towards the synthetic peptides; thus is not a potential skin sensitizer under the experimental conditions of the in chemico Direct Peptide Reactivity Assay (DPRA) method.
- Executive summary:
In the course of this study, the skin sensitisation potential of the test item was studied using the Direct Peptide Reactivity Assay method (DPRA Method). For the test chemical and positive control substance, in order to derive a prediction, two independent tests were conducted, one with cysteine and lysine peptides each. The results of the two valid runs were used for the classification of the test item. Peptide depletion which resulted from the positive control cinnamaldehyde was 65.49 % ± 0.31 % for cysteine peptides and 52.71 % ± 0.87 % for lysine peptides, fulfilling all acceptance criteria for the positive control. The mean back-calculated peptide concentrations of the reference control replicates were within the expected molarity concentration range for cysteine (0.48 – 0.50 mM) and lysine peptides (0.49 mM) and the CV % for the nine reference controls B and C in acetonitrile were 1.9 % and 0.4 % percentages for cysteine and lysine peptides. For each peptide, all validity criteria were met, confirming the validity of the assay. The percent cysteine peptide depletion value of the test item was 9.40 % ± 7.27 % while the percent lysine peptide depletion was 1.27 % ± 0.71 %. The mean depletion value of the peptides was used to categorize the test chemical in one of the four classes of reactivity. No co-elution was observed with either cysteine or lysine peptides; therefore, the cysteine 1:10 / lysine 1:50 prediction model was used for the discrimination between sensitizers and non-sensitizers. The mean peptide depletion of the test item was 5.34 %, which did not exceed the 6.38 % threshold of the applicable prediction model and fell into the no or minimal reactivity class.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
